DE2120426A1 - Varicellavaccine - Google Patents

Varicellavaccine

Info

Publication number
DE2120426A1
DE2120426A1 DE19712120426 DE2120426A DE2120426A1 DE 2120426 A1 DE2120426 A1 DE 2120426A1 DE 19712120426 DE19712120426 DE 19712120426 DE 2120426 A DE2120426 A DE 2120426A DE 2120426 A1 DE2120426 A1 DE 2120426A1
Authority
DE
Germany
Prior art keywords
virus
varicella
vaccine
tissue culture
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712120426
Other languages
German (de)
English (en)
Inventor
Maurice Ralph Lafayette Hill; Buynak Eugene Bernard North Wales; Pa. Hilleman (V.St.A.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2120426A1 publication Critical patent/DE2120426A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE19712120426 1970-04-28 1971-04-26 Varicellavaccine Pending DE2120426A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3276970A 1970-04-28 1970-04-28

Publications (1)

Publication Number Publication Date
DE2120426A1 true DE2120426A1 (de) 1971-11-11

Family

ID=21866708

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712120426 Pending DE2120426A1 (de) 1970-04-28 1971-04-26 Varicellavaccine

Country Status (11)

Country Link
AT (1) AT303965B (cg-RX-API-DMAC7.html)
AU (1) AU2788871A (cg-RX-API-DMAC7.html)
BE (1) BE766333A (cg-RX-API-DMAC7.html)
DE (1) DE2120426A1 (cg-RX-API-DMAC7.html)
ES (1) ES390603A1 (cg-RX-API-DMAC7.html)
FR (1) FR2092100B1 (cg-RX-API-DMAC7.html)
GB (1) GB1293310A (cg-RX-API-DMAC7.html)
HU (1) HU163131B (cg-RX-API-DMAC7.html)
IL (1) IL36649A0 (cg-RX-API-DMAC7.html)
NL (1) NL7103524A (cg-RX-API-DMAC7.html)
ZA (1) ZA712711B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043847A4 (en) * 1980-01-25 1982-07-06 Wistar Inst HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2952825B1 (fr) 2009-11-24 2012-05-25 Goaster Jacqueline Le Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043847A4 (en) * 1980-01-25 1982-07-06 Wistar Inst HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.

Also Published As

Publication number Publication date
AU2788871A (en) 1972-10-26
HU163131B (cg-RX-API-DMAC7.html) 1973-06-28
AT303965B (de) 1972-12-27
BE766333A (fr) 1971-10-27
NL7103524A (cg-RX-API-DMAC7.html) 1971-11-01
ES390603A1 (es) 1974-04-01
ZA712711B (en) 1972-12-27
FR2092100B1 (cg-RX-API-DMAC7.html) 1974-08-30
GB1293310A (en) 1972-10-18
FR2092100A1 (cg-RX-API-DMAC7.html) 1972-01-21
IL36649A0 (en) 1971-06-23

Similar Documents

Publication Publication Date Title
DE69215355T2 (de) Stabilisierter Varizella-Lebendimpfstoff
DE3911442A1 (de) Impfstoff-praeparation
DE2516274C2 (de) Verfahren zum Herstellen eines abgeschwächten Zytomegalie-Virus-Impfstoffes
DE2708668A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
EP0173241B1 (de) Vakzine zur Behandlung der Harnwegsinfektionen
DE69923470T2 (de) Kombinationsimpfstoff gegen hav und masernvirus und verfahren zu seiner produktion
DE2463143C2 (de) Polyvalente Rindervirus-Lebendimpfstoffe
DE2553998C2 (de) Mumpsvaccin und Verfahren zu seiner Herstellung
DE2362067C2 (de) Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen
DE2323847C3 (de) Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion
CH414061A (de) Verfahren zur Herstellung eines Impfstoffes gegen Masern
DE2655691C2 (de) Temperaturempfindliche, vermehrungsfähige, nicht pathogene Varicella-Zoster-Viren, Verfahren zu ihrer Herstellung und diese Viren enthaltende Lebendvaccine
DE69306934T2 (de) Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff
DE2120426A1 (de) Varicellavaccine
DE4104728C2 (de) Verwendung eines Bakterien-Lysats zur Behandlung der atopischen Dermatitis
DE3034238A1 (de) Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben
CH616959A5 (cg-RX-API-DMAC7.html)
CH423095A (de) Verfahren zur Herstellung eines Tollwutimpfstoffes
DE2415353A1 (de) Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen
Jawetz et al. Studies on herpes simplex virus: VII. Immunological comparison of strains of herpes simplex
DE1265916B (de) Verfahren zur Herstellung eines Brucellose-Impfstoffs
DE2805311A1 (de) Respiratorische synzytial-vakzine
DE3740182C2 (de) Verfahren zur Herstellung eines Mutantenstamms von Bordetella bronchiseptica, der für einen Impfstoff für den Schutz von B. bronchiseptica-Infektionen nützlich ist, und daraus hergestellter AR-Impfstoff
DE2921829C2 (cg-RX-API-DMAC7.html)
DE1966436C3 (de) Verwendung einer Antigen-Immunserum-Kombination als Impfstoff